Latest Partnerships News

Rhythm Biosciences has completed the first commercial sale of its ColoSTAT® blood test for colorectal cancer, confirming the full clinical and logistical process is operational and ready for expansion.

Condor Energy has updated its corporate presentation revealing significant progress in Peru’s Tumbes Basin, highlighting a 1 trillion cubic feet gas discovery and a multi-billion barrel oil exploration portfolio. The company is moving towards converting its evaluation agreement into a full exploration licence while advancing commercial discussions for gas offtake.

NuEnergy Gas Limited has completed four wells under its Tanjung Enim Early Gas Sales Initiative, secured a binding gas sales agreement, and raised $3.5 million to advance its Indonesian coal bed methane projects.

Lynas Rare Earths and Japan Australia Rare Earths B.V. have extended their supply agreement to 2038, securing firm commitments for critical rare earths with a pricing floor and upside sharing mechanism.

Adherium Limited reports a strong uptick in Remote Patient Monitoring revenue and device activations, driven by new reimbursement codes and strategic partnerships, aiming for 10,000 RPM patients by year-end.

Aerometrex has won multiple government contracts worth $2.5 million over three years, reinforcing its position as a trusted local provider and enhancing revenue visibility.

ActivEX Limited has fully repaid its $2.3 million loan to Star Diamond Developments by transferring full ownership of its East Coast Gold and Copper subsidiary, leaving the company debt free and financially strengthened.

Nex Metals Explorations is progressing metallurgical testing at its Kookynie Tailings Project and broadening collaboration with WTAC, while navigating geopolitical challenges delaying its Egyptian exploration efforts.

Kingsland Minerals reports outstanding graphite assay results from its Leliyn project, advancing metallurgical testing with Quinbrook to assess battery anode material potential.

Dimerix Limited has completed dosing of the last adult patient in its ACTION3 Phase 3 trial for DMX-200, exceeding its recruitment target and setting the stage for key regulatory milestones.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.

ABx Group has discovered new high-extraction ionic rare earth zones at its Deep Leads project in Tasmania, accelerating the path to production within months of approval. This breakthrough enhances the project's commercial viability with rare earths critical for green technologies.